Suggestions
Donavan Cheng
Sr Director, Bioinformatics at Guardant Health
Professional Background
Donavan Cheng is a distinguished professional specializing in Bioinformatics and Genomics, bringing a wealth of expertise in the development of innovative data analysis pipelines. His focus on harnessing high-dimensional molecular profiling data, including Next-Generation Sequencing (NGS), microarray platforms, and multiplexed immunoassays for protein quantitation, positions him as a leader in the field.
With a keen interest in translational research, Donavan has dedicated his career to the identification of biomarkers crucial for drug development. His particular emphasis on genetic markers associated with sensitivity and resistance to targeted therapies in cancer reveals his commitment to pushing the boundaries of modern medicine. He has extensive experience in biomarker discovery, especially from his time at Roche, where he led analysis efforts for biomarkers in Inflammation and Virology therapy areas, focusing on diseases such as Hepatitis B Virus (HBV) and autoimmune disorders.
Currently, Donavan serves as the Senior Director of Bioinformatics at Guardant Health, where he showcases his profound expertise in developing and validating NGS molecular diagnostic assays. His efforts are pivotal in detecting clinically actionable mutations in cancer, thereby facilitating the advancement of personalized medicine. In his career, he has cultivated an impressive portfolio through his impactful roles across various esteemed organizations and institutions, contributing significantly to the scientific community.
Education and Achievements
Donavan Cheng completed his PhD in Biomedical Engineering at The Johns Hopkins University School of Medicine, a world-renowned institution known for its research in biomedical sciences. During his doctoral studies, he honed his skills and knowledge, which later became essential in his work in bioinformatics. Prior to this, he earned a Bachelor of Applied Science (BASc) in Engineering Science, with a focus on Biomedical Engineering from the University of Toronto, another prestigious institution recognized for its contributions to engineering and health sciences.
His educational background laid a strong foundation for his career, allowing him to navigate the complex challenges in bioinformatics and genomics with remarkable proficiency.
Notable Roles
Donavan has held several strategic positions in notable organizations throughout his career:
- Sr Director, Bioinformatics at Guardant Health: Here, he leads initiatives related to bioinformatics, focusing on the application of NGS in identifying actionable cancer mutations.
- Director of Product Management at Illumina: In this role, he oversaw product development in bioinformatics, ensuring the integration of cutting-edge technology and scientific innovation.
- Director - Oncology Bioinformatics and Data Sciences at Illumina: This position enabled Donavan to contribute towards leveraging bioinformatics in oncology to enhance patient outcomes through targeted therapies.
- Assistant Attending Bioinformatician at Memorial Sloan-Kettering Cancer Center: Donavan played an integral role at one of the leading cancer treatment and research institutions, focusing on bioinformatics strategies for cancer diagnosis and treatment.
- Group Leader: Clinical Bioinformatics at Memorial Sloan-Kettering Cancer Center: Leading a team, he drove advancements in clinical bioinformatics, providing invaluable insights into patient care.
- Senior Scientist - Bioinformatics at Hoffmann-La Roche: His tenure at Roche included significant contributions to biomarker discovery in various therapeutic areas.
- Senior Scientist at Roche Pharmaceuticals: Donavan's work in this role highlighted his expertise in bioinformatics and its application in drug development.
Contributions to the Field
Throughout his career, Donavan has been at the forefront of bioinformatics and genomics, consistently pushing for advancements in the identification of biomarkers. His experience with Next-Generation Sequencing, molecular diagnostics, targeted re-sequencing in DNA-Seq and RNA-Seq, and microarray gene expression profiling has made him a sought-after expert in the field. Some of the keywords related to his expertise include:
- Next-Generation Sequencing
- Molecular Diagnostics
- Biomarker Discovery
- Translational Research
- Biosignature Identification
- Network Analysis
With contributions to a variety of projects and collaborations, Donavan Cheng is not just a pioneer in his field, but also a mentor and leader guiding the next generation of scientists. His dedication to improving patient outcomes through better diagnostics and targeted therapies underscores his commitment to social responsibility and innovation in medicine.